Sacks, F
These examples are educational only and do not replace individualized medical review
For most patients, doctors consider several key factors when determining eligibility: Body mass index (BMI): Typically recommended for those with a BMI over 30, or over 27 if weight-related conditions such as diabetes, hypertension, or sleep apnea are present
Dosage: 20 to 40 mcg per day Frequency: Once daily Administration: Subcutaneous or intramuscular injection Timing: Post-workout on training days, morning on rest days Cycle length: 4 to 6 weeks Time off: Equal to time on (4-6 weeks minimum) Starting at the lower end of this range allows you to gauge how your body responds before increasing dosage
Quick answer In the research literature the 5 mg AOD-9604 vial is typically reconstituted with 3 mL of bacteriostatic water, and documented research protocols reference 300 mcg per dose drawn from the resulting solution
You may be ready to stop or down-titrate if: Cycles are regular (2635 days) Ovulation is consistent Luteal phase is stable (1014 days) Weight loss is ~510% Metabolic markers have improved At this point, the primary fertility benefit of GLP-1s has likely been achieved